Search

everythinglearnresearchcommunity

for

Search:↓

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

Finasteride reduces new brain cells in male mice, possibly causing depression.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.